Relationship between intra-operative vein graft treatment with DuraGraft ® or saline and clinical outcomes after coronary artery bypass grafting.
CONCLUSION: In this study, intra-operative treatment of SVGs with DuraGraft was associated with a lower risk of long-term adverse events suggesting that efficient intra-operative SVG treatment may reduce VGF-related complications post-CABG. These data warrant randomized clinical trials to validate these findings.
PMID: 30285502 [PubMed - as supplied by publisher]
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Coronary Artery Bypass Graft | Heart | Heart Attack | Statistics | Study